Connection

James Bearden to Angiotensin-Converting Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications James Bearden has written about Angiotensin-Converting Enzyme Inhibitors.
James Bearden
Connection Strength
0.039
Angiotensin-Converting Enzyme Inhibitors
  1. Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial. Int J Radiat Oncol Biol Phys. 2019 03 01; 103(3):686-696.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.